Skip to main content

Table 1 Demographic characteristics of 2303 patients

From: The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-oncological research group registration

 

Overall

University hospital

Affiliated hospitals

 
 

n = 2303 (%)

n = 420 (%)

n = 1883 (%)

P value

Age (years)

    

younger than 60

154 (6.7)

52 (12.4)

102 (5.4)

 

60-69

684 (29.7)

130 (31.0)

554 (29.4)

 

70-79

1117 (48.5)

199 (47.3)

918 (48.8)

 

80 or older

348 (15.1)

39 (9.3)

309 (16.4)

< 0.001

PSA at diagnosis

    

10.0 or less

963 (41.8)

225 (53.5)

738 (39.2)

 

10.1-20

554 (24.1)

98 (23.3)

456 (24.2)

 

greater than 20

786 (34.1)

97 (23.1)

689 (36.6)

< 0.001

Gleason score

    

2-6

906 (39.3)

146 (34.8)

760 (40.3)

 

7

722 (31.4)

175 (41.6)

547 (29.0)

 

8-10

675 (29.3)

99 (23.6)

576 (30.6)

< 0.001

Clinical T stage

    

T1

766 (33.3)

183 (43.6)

583 (31.0)

 

T2

933 (40.5)

134 (31.9)

799 (42.4)

 

T3

489 (21.2)

95 (22.6)

394 (20.9)

 

T4

115 (5.0)

8 (1.9)

107 (5.7)

< 0.001

  1. Chi-square test.